Stocks of the Hour: PainChek, Chimeric Therapeutics, Torque Metals
Stocks of the Hour: PainChek, Chimeric Therapeutics, Torque Metals
To register for Friday's webinar click here.
要注册参加周五的网络研讨会，请单击此处。
PainChek (ASX:PCK), developer of the world's first smart based pain assessment and monitoring application, has announced it has established a reseller agreement with Nourish Care, a leading UK care management software provider. The agreement has an initial 12-month term with an opportunity to renew by both parties and will facilitate sales of the PainChek digital pain assessment app. Shares are trading 3.45 per cent lower at 2.8 cents.
全球首款基于智能的疼痛评估和监测应用程序的开发商PainChek（澳大利亚证券交易所股票代码：PCK）宣布已与英国领先的护理管理软件提供商Nourish Care签订了经销商协议。该协议的初始期限为12个月，双方都有机会续订，并将促进PainChek数字疼痛评估应用程序的销售。股价下跌3.45％，至2.8美分。
Chimeric Therapeutics (ASX:CHM) has highlighted recent successes and provided insight into key clinical catalysts for 2024. All 2023 milestones successfully accomplished establishing the foundation for multiple significant clinical catalysts in 2024. Shares are trading 3.45 per cent lower at 2.8 cents.
Chimeric Therapeutics（澳大利亚证券交易所股票代码：CHM）重点介绍了最近取得的成功，并对2024年的关键临床催化剂提供了见解。2023 年的所有里程碑都成功地完成了在 2024 年为多种重要临床催化剂奠定了基础。股价下跌3.45％，至2.8美分。
Torque Metals (ASX:TOR) has provided results from its reverse circulation ("RC") and Diamond drill campaign at the New Dawn Lithium Project. The results show consistent and impressive high-grade lithium results. Shares are trading flat at 16 cents.
Torque Metals（澳大利亚证券交易所股票代码：TOR）已经提供了其在新黎明锂项目的反循环（“RC”）和钻石钻探活动的结果。结果显示出一致且令人印象深刻的高等级锂电池结果。股价持平至16美分。
